Aplastic anaemia trials in China

In China 25 Also abroad 68

17 of 25 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia
Where
Tianjin
Age
18 years and over
People
37
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07287228
Phase 2Not yet taking people in China
Conditioning Regimen Containing Low-Dose ATG for the Treatment of AA Receiving sUCBT
Where
Hefei
Age
1 year to 50 years
People
59
Run by
Anhui Provincial Hospital
See details and how to joinNCT07885982
Phase 1/2Taking people
Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia
Where
Tianjin
Age
18 years and over
People
32
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07714512
No phaseTaking people
Peripheral Blood Versus Bone Marrow Plus Peripheral Blood Grafts for Haploidentical Transplantation in Severe Aplastic Anemia
Where
Beijing
Age
18 years to 40 years
People
180
Run by
Peking University People's Hospital
See details and how to joinNCT07629947
Phase 1/2Enrolling by invitation
Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA
Where
Beijing
Age
6 years to 60 years
People
40
Run by
Chinese PLA General Hospital
See details and how to joinNCT07299123
No phaseNot yet taking people in China
Clinical Study on the Preservation of Ovarian Function in Patients With Aplastic Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation Using Goserelin
Where
Hangzhou, Kunming, Wuhan, Zhengzhou
Age
14 years to 50 years
People
132
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07552506
Phase 2Taking people
Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA
Where
Suzhou
Age
18 years to 65 years
People
66
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07400341
No phaseTaking people
A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia
Where
Hangzhou, Suzhou, Xuzhou
Age
14 years and over
People
224
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07499284
No phaseTaking people
Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study
Where
Taiyuan
Age
6 years to 75 years
People
110
Run by
Shanxi Bethune Hospital
See details and how to joinNCT06650553
Phase 2Not yet taking people in China
Efficacy and Safety of UCBT With TMI -Based Conditioning Regimen for Adults With Refractory/Relapsed Aplastic Anemia
Where
Tianjin
Age
18 years to 50 years
People
11
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07078721
Phase 2Taking people
Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia
Where
Tianjin
Age
65 years and over
People
65
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07010237
Phase 2Taking people
Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin A
Where
Beijing
Age
18 years and over
People
40
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06802055
No phaseNot yet taking people in China
Treatment of Transfusion-dependent Nonsevere Aplastic Anemia With Luspatercept: a Multicenter Prospective Clinical Study
Where
Hangzhou
Age
18 years to 80 years
People
90
Run by
The First Affiliated Hospital of Zhejiang Chinese Medical University
See details and how to joinNCT06964971
Phase 1/2Not yet taking people in China
Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic Anemia
Where
Tianjin
Age
18 years and over
People
125
Run by
Keymed Biosciences Co.Ltd
See details and how to joinNCT06791824
Early phase 1Taking people
CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia
Where
Hanzhou
People
30
Run by
Zhejiang University
See details and how to joinNCT06633328
Phase 2Taking people
Clinical Study on Modified Allogeneic Hematopoietic Stem Cell Transplantation Regimen for Severe Aplastic Anemia
Where
Kunming
Age
3 years to 65 years
People
30
Run by
Hematology department of the 920th hospital
See details and how to joinNCT06378060
Phase 2Taking people
Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
Where
Tianjin
Age
18 years to 70 years
People
20
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06254560